SEC 13F Intelligence

Athanor Capital, LP / ALXN

Athanor Capital, LP’s Alexion Pharmaceuticals Inc Position

Does Athanor Capital, LP own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 350.8K shares worth $64M in Q2 2021; the fund’s latest 13F (Q1 2023) no longer reports it.

Position Value
$64M
Q2 2021
Shares
350.8K
% of Portfolio
+2.31%
Quarters Held
5
position exited

Position History ALXN

Reported value by quarter
Q2 ’20: $463,000Q2 ’20Q3 ’20: $528,000Q3 ’20Q4 ’20: $26MQ4 ’20Q1 ’21: $23MQ1 ’21Q2 ’21: $64MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021350.8K$64M+2.31%
Q1 2021151.2K$23M+0.54%
Q4 2020164.9K$26M+0.59%
Q3 20204.6K$528,000+0.02%
Q2 20204.1K$463,000+0.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Athanor Capital, LP’s full portfolio or all institutional holders of ALXN.